Insulin aspart, recombinant Subcutaneous and Lacosamide Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lacosamide Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lacosamide
Brand name: Vimpat
Synonyms: Lacosamide (oral/injection), Lacosamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lacticare-HC
- Insulin aspart, recombinant Subcutaneous-Lactulose
- Insulin aspart, recombinant Subcutaneous-Lactulose Oral Solution
- Insulin aspart, recombinant Subcutaneous-Lactulose Powder for Oral Solution
- Insulin aspart, recombinant Subcutaneous-Lactulose Solution (Encephalopathy)
- Insulin aspart, recombinant Subcutaneous-Lamictal
- Lacosamide Tablets-Insulin degludec
- Lacosamide Tablets-Insulin Degludec (U-100) Prefilled Pens
- Lacosamide Tablets-Insulin Degludec (U-100) Vials
- Lacosamide Tablets-Insulin Degludec (U-200) Prefilled Pens
- Lacosamide Tablets-Insulin degludec and liraglutide
- Lacosamide Tablets-Insulin degludec and liraglutide Subcutaneous